CA
PBH icon

Clearstead Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Clearstead Advisors’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615 Buy
+13
New +$668 ﹤0.01% 2859
2026
Q1 		– Sell
-1
Closed -$62 – 2683
2025
Q4 		$62 Sell
1
-6
-86% -$367 ﹤0.01% 2584
2025
Q3 		$437 Sell
7
-260
-97% -$18.1K ﹤0.01% 2755
2025
Q2 		$21.3K Sell
267
-17
-6% -$1.42K ﹤0.01% 1600
2025
Q1 		$24.4K Hold
284
– – ﹤0.01% 1362
2024
Q4 		$22.2K Hold
284
– – ﹤0.01% 1352
2024
Q3 		$20.5K Sell
284
-100
-26% -$7.08K ﹤0.01% 1408
2024
Q2 		$26.4K Buy
+384
New +$26K ﹤0.01% 1303

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Clearstead Advisors's PBH Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 13 shares worth $615. The stake represents ﹤0.01% of the portfolio and ranks #2859 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in PBH as recently as Q4 2025.

Clearstead Advisors first reported a position in PBH in Q2 2024 and has held it in 8 quarters since. The position peaked at $26.4K in Q2 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Clearstead Advisors held 13 shares of Prestige Consumer Healthcare worth $615 as of Q2 2026.
  • Prestige Consumer Healthcare was a new Clearstead Advisors position in Q2 2026.
  • Prestige Consumer Healthcare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2859 holding.
  • Clearstead Advisors first reported a position in Prestige Consumer Healthcare in Q2 2024 and has held it in 8 quarters since.
  • Clearstead Advisors's Prestige Consumer Healthcare position peaked at $26.4K in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.